Plain-English translation of NCT05100992 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Coronary Artery Disease research guide โThis is an observational registry study that gathers real-world information from patients who are receiving treatment for a specific type of heart blockage called a coronary bifurcation lesion. Researchers want to understand which treatment techniques doctors use most often, how well they work, and what outcomes patients experience. Your participation helps doctors learn which approaches are safest and most effective for this challenging type of heart disease.
Bifurcation lesions โ blockages that occur where a heart artery splits into two branches โ are particularly difficult to treat, and doctors use several different techniques to open them up. This study exists to understand which techniques are being used in real practice, how often they succeed, and whether some methods work better than others, so that doctors can provide the best care possible.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
As a participant, you would have your medical information collected and tracked as you receive your heart treatment at the hospital. Doctors and researchers will gather details about your procedure, the techniques used to treat your blockage, and how you recover over time. This is not an experimental treatment โ you will receive standard care โ but your information will be added to a database that helps doctors understand real-world outcomes.
AI-generated summary from trial data ยท Jul 7, 2026 ยท Not medical advice
United States
Minneapolis Heart Institute Foundation
Enrollment target
~4,000 participants
Started
April 2020
Primary completion
January 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2021.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Emmanouil Brilakis, MD, PhD
Minneapolis Heart Institute Foundation
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.